MIRA Pharmaceuticals Inc.
1.17
0.00 (0.00%)
At close: Jan 15, 2025, 2:46 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 4.60M 350.98K 2.81M 3.49K
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments 69.15K n/a n/a 5.89K
Other Long-Term Assets n/a n/a 445.61K 18.88K
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 255.66K 143.43K 100.00K n/a
Total Current Assets 4.86M 494.40K 2.91M 3.49K
Property-Plant & Equipment 5.06K 363.67K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a
Total Long-Term Assets 74.21K 363.67K 445.61K 24.77K
Total Assets 4.93M 858.07K 3.36M 28.26K
Account Payables 538.56K 905.55K 776.01K n/a
Deferred Revenue n/a n/a n/a n/a
Short-Term Debt 5.06K 406.96K 293.06K 90.00K
Other Current Liabilities 14.47K 57.52K 24.74K 364.00
Total Current Liabilities 558.10K 1.37M 1.09M 90.36K
Long-Term Debt n/a 84.27K n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a
Total Long-Term Liabilities n/a 84.27K n/a n/a
Total Liabilities 558.10K 1.45M 1.09M 90.36K
Total Debt 5.06K 491.23K 293.06K 90.00K
Common Stock 1.48K 6.66K 6.34K 5.89K
Retained Earnings -21.29M -9.30M -2.24M -67.99K
Comprehensive Income n/a n/a n/a -5.89K
Shareholders Equity 4.37M -596.23K 2.26M -62.11K
Total Investments 69.15K n/a n/a 5.89K